Company intelligence / Profile preview

Gencellmed

Seoul, Seoul, South Koreagencellmed.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Gencellmed develops proprietary oncolytic virus therapies using engineered HSV to selectively target and destroy cancer cells while activating the immune system. The company also commercializes an ADC technology platform and integrates genome analysis/liquid biopsy capabilities. Three patents have been granted related to recombinant herpes simplex viruses expressing fused proteins for targeted cancer therapy, with a focus on immunology and monoclonal antibodies. No published clinical trial results as of the latest data.[1][2][3]

Therapeutic areas
Oncology
Modalities
Oncolytic viruses (HSV-1 based)Antibody-drug conjugates (ADC platform)[1][3]Gene delivery vectors[2]Liquid biopsy technologies[3]Genome analysis platforms[3]
Industry
Biotech
02

Drug pipeline

6 assets

GCM-101

Preclinical

5 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Gencellmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gencellmed.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call